US8598210, Table XV, 8::US8722895, 8: {[5-(4-Cyanophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid

ID: ALA3646219

Chembl Id: CHEMBL3646219

PubChem CID: 59513097

Max Phase: Preclinical

Molecular Formula: C15H11N3O4

Molecular Weight: 297.27

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  [C-]#[N+]c1ccc(-c2cnc(C(=O)NCC(=O)O)c(O)c2)cc1

Standard InChI:  InChI=1S/C15H11N3O4/c1-16-11-4-2-9(3-5-11)10-6-12(19)14(17-7-10)15(22)18-8-13(20)21/h2-7,19H,8H2,(H,18,22)(H,20,21)

Standard InChI Key:  WESRXHMJQHLLSE-UHFFFAOYSA-N

Associated Targets(Human)

EGLN3 Tclin Egl nine homolog 3 (250 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGLN1 Tclin Egl nine homolog 1 (1702 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
VEGFA Tclin Vascular endothelial growth factor A (159 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 297.27Molecular Weight (Monoisotopic): 297.0750AlogP: 1.82#Rotatable Bonds: 4
Polar Surface Area: 103.88Molecular Species: ACIDHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 2.73CX Basic pKa: 3.37CX LogP: -0.97CX LogD: -4.37
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.75Np Likeness Score: -0.11

References

1.  (2014)  Prolyl hydroxylase inhibitors and method of use, 
2.  (2013)  Prolyl hydroxylase inhibitors and methods of use, 

Source

Source(1):